will discuss the competencies necessary to ensure that shared decision making is a core component of cancer treatment planning.
 
Patient perspective: Understanding patient preferences and engaging patients in decision making
• Jessie Gruman, Center for Advancing Health Research perspective: Are patient preferences currently incorporated in treatment decisions?
• Nancy Keating, Harvard Medical School and Brigham and Women’s Hospital Decision quality
• Karen Sepucha, Massachusetts General Hospital and Harvard Medical School Incorporation of comparative effectiveness research (CER) into shared decision making: Promises and challenges
• Sheldon Greenfield, University of California, Irvine Shared decision making in practice
• Jeffrey Peppercorn, Duke University
 
Discussion (30 minutes)
 
Questions:

• How can patient preferences be assessed in the context of medical decision making?Are patient preferences usually taken into account?

• What is the role of a patient when discussing a treatment plan? What is the role of the care team?

• What are the barriers to incorporating patient preferences and shared decision making in cancer treatment planning and which barriers can be modified?

• What is decision quality? How can biomedical research findings (for example, comparative effectiveness research) be communicated to patients to inform preference-sensitive decision making?

 
12:30 p.m. Lunch


The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement